159 related articles for article (PubMed ID: 29617079)
1. Effect of phyllanthus niruri on metabolic parameters of patients with kidney stone: a perspective for disease prevention.
Pucci ND; Marchini GS; Mazzucchi E; Reis ST; Srougi M; Evazian D; Nahas WC
Int Braz J Urol; 2018; 44(4):758-764. PubMed ID: 29617079
[TBL] [Abstract][Full Text] [Related]
2. Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients.
Nishiura JL; Campos AH; Boim MA; Heilberg IP; Schor N
Urol Res; 2004 Oct; 32(5):362-6. PubMed ID: 15221244
[TBL] [Abstract][Full Text] [Related]
3. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation.
Freitas AM; Schor N; Boim MA
BJU Int; 2002 Jun; 89(9):829-34. PubMed ID: 12010223
[TBL] [Abstract][Full Text] [Related]
4. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
5. Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in rat.
Sakly R; Bardaoui M; Neffati F; Moussa A; Zakhama A; Najjar MF; Hammami M
Ann Nutr Metab; 2005; 49(2):132-8. PubMed ID: 15860912
[TBL] [Abstract][Full Text] [Related]
6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
7. [Sodium excretion in children with lithogenic disorders].
Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
[TBL] [Abstract][Full Text] [Related]
8. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
[TBL] [Abstract][Full Text] [Related]
9. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
[TBL] [Abstract][Full Text] [Related]
10. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
[TBL] [Abstract][Full Text] [Related]
11. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
[TBL] [Abstract][Full Text] [Related]
12. Weight, age and coefficients of variation in renal solute excretion.
Perry GM; Scheinman SJ; Asplin JR
Nephron Physiol; 2012; 122(1-2):13-8. PubMed ID: 23595094
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
Schwille PO; Schmiedl A; Wipplinger J
Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
[TBL] [Abstract][Full Text] [Related]
14. Urine composition in patients with renal stone disease during treatment with allopurinol.
Tiselius HG; Larsson L
Scand J Urol Nephrol; 1980; 14(1):65-71. PubMed ID: 7375845
[TBL] [Abstract][Full Text] [Related]
15. Phytotherapy and Herbal Medicines for Kidney Stones.
Emiliani E; Jara A; Kanashiro AK
Curr Drug Targets; 2021; 22(1):22-30. PubMed ID: 32990535
[TBL] [Abstract][Full Text] [Related]
16. Can 24-hour urine stone risk profiles predict urinary stone composition?
Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M
J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026
[TBL] [Abstract][Full Text] [Related]
17. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy.
Oehlschläger S; Albrecht S; Hakenberg OW; Schrödter S; Froehner M; Manseck A; Wirth MP
Urology; 2003 Jul; 62(1):17-21. PubMed ID: 12837412
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of some biochemical parameters in pyridoxine-treated calcium oxalate renal stone formers.
Revúsová V; Gratzlová J; Zvara V; Kridl J; Suchánek B; Breza J
Urol Int; 1977; 32(4):348-52. PubMed ID: 929778
[TBL] [Abstract][Full Text] [Related]
19. The role of overweight and obesity in calcium oxalate stone formation.
Siener R; Glatz S; Nicolay C; Hesse A
Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
[TBL] [Abstract][Full Text] [Related]
20. The relationship of the urinary cations, Calcium, Magnesium, Sodium and Potassium, in patients with Renal Calculi.
Welshman SG; McGeown MG
Br J Urol; 1975 Jun; 47(3):237-42. PubMed ID: 1139114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
